Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlo Gambacorti-Passerini"'
Autor:
Giorgio La Nasa, Bruno Martino, Olga Mulas, Giovanni Caocci, Marianna Greco, Sara Galimberti, Carlo Carcassi, Elisabetta Abruzzese, Carlo Gambacorti Passerini, Sara Lai, Claudia Baratè, Roberto Littera, Claudia Labate, Malgorzata Monika Trawinska, Paola Ragatzu
Publikováno v:
Experimental hematology. 43(12)
Several factors are predictive of treatment-free remission (TFR) in chronic myeloid leukemia (CML), but few data exist on the role of natural killer (NK) cells and their killer-cell immunoglobulin-like receptors (KIRs). KIR and human leukocyte antige
Autor:
Raymond B. Birge, Alessandra Gambacurta, Valentina Martini, Luca Mologni, Gabriella Marfe, Paola Sinibaldi-Salimei, Paolo de Fabritis, Elisabetta Abruzzese, Sergio Amadori, Carla Di Stefano, Carlo Gambacorti-Passerini, Tiziana Ottone
Publikováno v:
Experimental hematology. 39(6)
Objective: As a better understanding of the molecular basis of carcinogenesis has emerged, oncogene-specific cell-signaling pathways have been successfully targeted to treat human malignances. Despite impressive advances in oncogene-directed therapeu
Autor:
Paola Stano, Edoardo Marchesi, Carlo Gambacorti-Passerini, Addolorata Maria Luce Coluccia, Holger Ruchatz
Publikováno v:
Experimental hematology. 31(4)
Objectives The t(2;5) translocation results in a 80-kDa oncogenic fusion protein consisting of NPM and the kinase domain of the tyrosine kinase ALK and is present in over half the cases of anaplastic large cell lymphoma (ALCL). NPM/ALK exerts its tra